Anastrozole and Methylene Blue Interaction

Avoid
Mechanism-based 64% confidence

Anastrozole and Methylene Blue have a potentially harmful interaction with 64% confidence. Both Anastrozole and Methylene Blue carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. These compounds primarily affect different organ systems.

Compound Profiles

Anastrozole

Aromatase Inhibitor | Estrogen Management

Anastrozole competitively binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), reversibly inhibiting its catalytic activity. Aromatase is responsible for the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain.

Half-life: ~40-50 hours Typical dose: 0.25-0.5mg EOD or E3D (estrogen management) pct, anabolic
aromatase androgenicaromatase inhibitorestrogenichepatotoxic
View full profile

Methylene Blue

Mitochondrial Electron Carrier | Cognitive & Neuroprotection

Methylene blue functions as a redox cycling agent in mitochondria. In its oxidized form, it accepts electrons from NADH through Complex I and is reduced to leucomethylene blue.

Half-life: ~5-6 hours Typical dose: 0.5-2 mg/kg oral (low-dose nootropic) cognitive, longevity
dopamine receptorserotonin receptor blood pressure raisinghepatotoxicphotosensitizingserotonergic
View full profile

Combined Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Pituitary
low
Brain
low

Shared Safety Flags

2x 2 hepatotoxic compounds (Anastrozole, Methylene Blue). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds share the teratogenic safety flag (Anastrozole, Methylene Blue). Monitor accordingly.

Frequently Asked Questions

Can I take Anastrozole with Methylene Blue?

Combining Anastrozole with Methylene Blue is not recommended. Both Anastrozole and Methylene Blue carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Anastrozole and Methylene Blue safe together?

This combination carries significant risk. Both Anastrozole and Methylene Blue carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Anastrozole and Methylene Blue?

Both Anastrozole and Methylene Blue carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 64% confidence and is inferred from pharmacological mechanism analysis.

How should I time Anastrozole and Methylene Blue?

Anastrozole has a half-life of ~40-50 hours and Methylene Blue has a half-life of ~5-6 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Anastrozole vs Methylene Blue

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.